Myocardial oedema contributes to interstitial expansion and associates with mechanical and electrocardiographic changes in takotsubo syndrome: a CMR T1 and T2 mapping study.

AIMS myocardial oedema is largely represented in takotsubo syndrome (TTS) and may contribute to alter the myocardium morphology and function. The aim of the study is to describe relationships between oedema, mechanical, and electrical abnormalities in TTS. METHODS AND RESULTS the study included n = 32 hospitalized TTS patients and n = 23 controls. Cardiac magnetic resonance (CMR) with tissue mapping and feature tracking was performed with concomitant 12-lead electrocardiogram (ECG) recording. Mean age of TTS was 72 ± 12 years old, 94% women. Compared with controls, patients had higher left ventricular (LV) mass, worse systolic function, higher septal native T1 (1116 ± 73 msec vs. 970 ± 23 msec, P < 0.001), T2 (56 ± 5 msec vs. 46 ± 2 msec, P < 0.001), and extracellular volume (ECV) fraction (32 ± 5% vs. 24 ± 1%, P < 0.001). TTS patients had higher apicobasal gradient of T2 values (12 ± 6 msec vs. 2 ± 6 msec, P < 0.001); basal LV wall displayed higher native T1, T2, and ECV (all P < 0.002) but similar circumferential strain against controls (-23 ± 3% vs. -24 ± 4%, P = 0.351). In the TTS cohort, septal T2 values showed significant correlations with native T1 (r = 0.609, P < 0.001), ECV (r = 0.689, P < 0.001), left ventricular ejection fraction (r = -0.459, P = 0.008) and aVR voltage (r = -0.478, P = 0.009). Negative T-wave voltage and QTc length correlated with apicobasal T2 mapping gradient (r = 0.499, P = 0.007 and r = 0.372, P = 0.047, respectively) but not with other tissue mapping measurements. CONCLUSIONS CMR T1 and T2 mapping demonstrated increased myocardial water content conditioning interstitial expansion in acute TTS, detected even outside areas of abnormal wall motion. Oedema burden and distribution associated with mechanical and electrocardiographic changes, making it a potential prognostic marker and therapeutic target in TTS.

[1]  L. Bachárová,et al.  ECG in left ventricular hypertrophy: A change in paradigm from assessing left ventricular mass to its electrophysiological properties. , 2022, Journal of electrocardiology.

[2]  N. Brunetti,et al.  Gender Differences in Takotsubo Syndrome. , 2022, Journal of the American College of Cardiology.

[3]  J. Ghadri,et al.  Dynamic Trend of Myocardial Edema in Takotsubo Syndrome: A Serial Cardiac Magnetic Resonance Study , 2022, Journal of clinical medicine.

[4]  S. Heymans,et al.  Pathophysiology of Takotsubo syndrome – a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology – Part 1: overview and the central role for catecholamines and sympathetic nervous system , 2021, European journal of heart failure.

[5]  C. Autore,et al.  Long-term management of Takotsubo syndrome: a not-so-benign condition. , 2021, Reviews in cardiovascular medicine.

[6]  C. Autore,et al.  Novel Imaging and Genetic Risk Markers in Takotsubo Syndrome , 2021, Frontiers in Cardiovascular Medicine.

[7]  E. Nagel,et al.  Cardiac biomarkers in chronic kidney disease are independently associated with myocardial edema and diffuse fibrosis by cardiovascular magnetic resonance , 2021, Journal of Cardiovascular Magnetic Resonance.

[8]  M. Frenneaux,et al.  The early dynamic of ECG in takotsubo syndrome presenting with ST-elevation: A comparison with age and gender-matched ST-elevation myocardial infarction. , 2020, International journal of cardiology.

[9]  C. Autore,et al.  A systematic review on focal takotsubo syndrome: a not-so-small matter , 2020, Heart Failure Reviews.

[10]  L. Brunereau,et al.  Cardiac magnetic resonance for assessment of cardiac involvement in Takotsubo syndrome: Do we still need contrast administration? , 2020, International journal of cardiology.

[11]  E. Nagel,et al.  Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions - Comparison of uremic, hypertensive and hypertrophic cardiomyopathy. , 2020, International journal of cardiology.

[12]  E. Nagel,et al.  CMR in Nonischemic Myocardial Inflammation: Solving the Problem of Diagnosing Myocarditis or Still Diagnostic Ambiguity? , 2020, JACC. Cardiovascular imaging.

[13]  A. Kono,et al.  Clinical impact of native T1 mapping for detecting myocardial impairment in takotsubo cardiomyopathy. , 2019, European heart journal cardiovascular Imaging.

[14]  H. Schild,et al.  Cardiac magnetic resonance including parametric mapping in acute Takotsubo syndrome: Preliminary findings. , 2019, European journal of radiology.

[15]  A. Henning,et al.  Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy , 2019, Circulation.

[16]  A. Davenport,et al.  Acute changes in cardiac structural and tissue characterisation parameters following haemodialysis measured using cardiovascular magnetic resonance , 2019, Scientific Reports.

[17]  C. Autore,et al.  Admission heart rate and in-hospital course of patients with Takotsubo syndrome. , 2018, International journal of cardiology.

[18]  F. Moeller,et al.  Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review. , 2018, Journal of the American College of Cardiology.

[19]  René M. Botnar,et al.  Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I - analytical validation and clinical qualification , 2018, Journal of Cardiovascular Magnetic Resonance.

[20]  N. Brunetti,et al.  Inflammatory patterns in Takotsubo cardiomyopathy and acute coronary syndrome: A propensity score matched analysis. , 2018, Atherosclerosis.

[21]  A. Henning,et al.  Persistent Long-Term Structural, Functional, and Metabolic Changes After Stress-Induced (Takotsubo) Cardiomyopathy , 2017, Circulation.

[22]  Richard B. Thompson,et al.  Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) , 2017, Journal of Cardiovascular Magnetic Resonance.

[23]  C. Autore,et al.  QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy: Time for reappraisal. , 2017, Journal of cardiology.

[24]  Yoshio Kobayashi,et al.  Myocardial Edema in Takotsubo Syndrome - Serial Cardiovascular Magnetic Resonance Imaging of the Natural Course. , 2017, Circulation journal : official journal of the Japanese Circulation Society.

[25]  E. Schelbert,et al.  Diffuse Myocardial Fibrosis Reduces Electrocardiographic Voltage Measures of Left Ventricular Hypertrophy Independent of Left Ventricular Mass , 2017, Journal of the American Heart Association.

[26]  G. Pedrizzetti,et al.  Principles of cardiovascular magnetic resonance feature tracking and echocardiographic speckle tracking for informed clinical use , 2016, Journal of Cardiovascular Magnetic Resonance.

[27]  Eike Nagel,et al.  T1 Mapping in Characterizing Myocardial Disease: A Comprehensive Review. , 2016, Circulation research.

[28]  Matthias Gutberlet,et al.  Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial. , 2016, Journal of the American College of Cardiology.

[29]  Jeroen J. Bax,et al.  Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. , 2015, The New England journal of medicine.

[30]  Hyuk-Jae Chang,et al.  Transient apical wall thickening in patients with stress cardiomyopathy: Prevalence, profile, and impact on clinical course. , 2015, International Journal of Cardiology.

[31]  J. Madias Transient attenuation of the amplitude of the QRS complexes in the diagnosis of Takotsubo syndrome , 2014, European heart journal. Acute cardiovascular care.

[32]  W. Desmet,et al.  Time course of electrocardiographic changes in transient left ventricular ballooning syndrome. , 2013, International journal of cardiology.

[33]  D. Corrado,et al.  Apicobasal gradient of left ventricular myocardial edema underlies transient T-wave inversion and QT interval prolongation (Wellens' ECG pattern) in Tako-Tsubo cardiomyopathy. , 2013, Heart rhythm.

[34]  G. Marazzi,et al.  Observational study on Takotsubo-like cardiomyopathy: clinical features, diagnosis, prognosis and follow-up , 2012, BMJ Open.

[35]  M. Robson,et al.  Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.

[36]  Paaladinesh Thavendiranathan,et al.  Improved Detection of Myocardial Involvement in Acute Inflammatory Cardiomyopathies Using T2 Mapping , 2012, Circulation. Cardiovascular imaging.

[37]  G. Schuler,et al.  Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. , 2011, JAMA.

[38]  K. Cha,et al.  Relationship between Giant Negative T‐Wave and Severity of Apical Hypertrophy in Patients with Apical Hypertrophic Cardiomyopathy , 2010, Echocardiography.

[39]  R. Stewart,et al.  Myocardial microvascular permeability, interstitial oedema, and compromised cardiac function. , 2010, Cardiovascular research.

[40]  O. Simonetti,et al.  T2 quantification for improved detection of myocardial edema , 2009, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[41]  J. Madias aVR, An Index of all ECG Limb Leads, with Clinical Utility for Monitoring of Patients with Edematous States, Including Heart Failure , 2009, Pacing and clinical electrophysiology : PACE.

[42]  C. Hamm,et al.  Immunohistological basis of the late gadolinium enhancement phenomenon in tako-tsubo cardiomyopathy. , 2009, European heart journal.

[43]  C. Hamm,et al.  Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. , 2007, European heart journal.